1. A phase 1/2a safety, pharmacokinetics, and efficacy study of the novel nucleoside analog FF‐10502‐01 for the treatment of advanced solid tumors. Issue 10 (7th March 2023) Authors: Janku, Filip; Javle, Milind M.; Sen, Shiraj; Pant, Shubham; Bramwell, Lindsay G.; Subbiah, Vivek; Way, Tracey; Wages, David S.; Wheeler, Catherine A.; Suzuki, Takeaki; Saeki, Kazunori; Subach, Ruth Ann; Madden, Timothy; Maier, Gary; Johansen, Mary J.; Cheung, Kin; Falchook, Gerald S. Journal: Cancer Issue: Volume 129:Issue 10(2023) Page Start: 1537 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗